Effect of improvement in anemia on electroneurophysiological markers (P300) of cognitive dysfunction in chronic kidney disease

Hemodialysis International

Volumn 10, Issue 3, 2006, Pages 267-273

  Singh, Narinder P ^a,b   Sahni, Vaibhav ^a   Wadhwa, Anshul ^a   Garg, Sandeep ^a   Bajaj, Satish K ^a   Kohli, Rajeev ^a   Agarwal, Satish K ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b NONE   (India)

Author keywords

Anemia; CKD; Cognitive dysfunction; Erythropoietin; Event related potentials; P300

Indexed keywords

PROTEIN P300; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG DOSE REGIMEN; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; PROTEIN DETERMINATION; TREATMENT DURATION;

ANEMIA; CHRONIC DISEASE; COGNITION DISORDERS; ERYTHROPOIETIN, RECOMBINANT; EVENT-RELATED POTENTIALS, P300; HEMOGLOBINS; HUMANS; KIDNEY DISEASES; REACTION TIME;

EID: 33745262328     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2006.00107.x     Document Type: Article

References (12)

1. United States Renal Data System: Excerpts from United States Renal Data System 1991 Annual Data Report. Annual erythropoietin report. Am J Kidney Dis. 1991; 18: 1-127.
2. Marsh JT, Brown WS, Wolcott D, et al. rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Int. 1991; 39: 155-163.
3. Pickett JL, Theberge DC, Brown WS, Schweitzer SU, Nissenson AR. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis. 1999; 33: 1122-1130.
4. Teschan PE, Ginn HE, Bourne JR, et al. Quantitative indices of clinical uremia. Kidney Int. 1979; 15: 676-697.
5. Goodin DS. Event related (Endogenous) potential. In: Aminoff MJ ed. Electrodiagnosis in Clinical Neurology. New York: Churchill Livingstone; 1986: 575-595.
6. St Clair DM, Blackwood DH, Christie JE. P3 and other long latency auditory evoked potentials in presenile dementia Alzheimer type and alcoholic Korsakoff syndrome. Br J Psychiatry. 1985; 147: 702-706.
7. Brown WS, Marsh JT, Wolcott D, et al. Cognitive function, mood and P3 latency: Effects of the amelioration of anemia in dialysis patients. Neuropsychologia. 1991; 29: 35-45.
8. Grimm G, Stockenhuber F, Schneeweiss B, Madl C, Zeitlhofer J, Schneider B. Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int. 1990; 38: 480-486.
9. Sagales T, Gimeno V, Planella MJ, Raguer N, Bartolome J. Effects of rHuEPO on Q-EEG and event-related potentials in chronic renal failure. Kidney Int. 1993; 44: 1109-1115.
10. Nuwer MR, Lehmann D, da Lopes Silva F, Matsuoka S, Sutherling W, Vibert JF. International Federation of Clinical Neurophysiology. IFCN guidelines for topographic and frequency analysis of EEGs and EPs: Report of an IFCN committee. Electroencephalogr Clin Neurophysiol. 1994; 91: 1-5.
11. Tandon OP. P3 event-related evoked potential in young adults. Indian J Physiol Pharmacol. 1990; 34: 191-194.
12. National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis. 2002;39 (Suppl 1): S1-S266.